No connection

Search Results

NIQ

BEARISH
$10.93 Live
NIQ Global Intelligence plc · NYSE
Target $19.23 (+75.9%)
$10.05 52W Range $20.39

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated May 01, 2026
Market cap
$3.23B
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
NIQ exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total failure across profitability, leverage, and operating efficiency metrics. While analysts maintain a target price of $19.23, this is starkly contradicted by a disastrous earnings track record with an average surprise of -201.36% and a recent Q/Q EPS collapse of -466.7%. The technical trend is purely bearish (0/100), and the stock has lost 42.5% of its value over the last year. Despite a modest Q/Q revenue increase, the fundamental health is too compromised to justify a bullish outlook.

Key Strengths

Positive Q/Q revenue growth of 9.23%
Significant gap between current price ($10.93) and analyst target ($19.23)
Relatively low Forward P/E of 9.13 (if earnings materialize)
Market capitalization of $3.23B provides some institutional scale
Price is currently trading near its 52-week low, limiting immediate downside volatility

Key Risks

Critical financial health failure (Piotroski F-Score 0/9)
Severe earnings instability with 0/3 quarters beating estimates
Catastrophic recent EPS growth decline of -466.7%
Strong bearish technical momentum (0/100 trend score)
Extreme disconnect between analyst projections and actual financial performance

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
14
Weak
Value
40
Future
20
Past
10
Health
0
Dividend
0
AI Verdict
High Risk / Avoid
Key drivers: Piotroski F-Score 0/9, Negative earnings surprises, Bearish price action
Confidence
90%
Value
40/100

Forward P/E of 9.13 suggests value, but earnings quality is extremely poor.

Positives
  • Low Forward P/E
Watchpoints
  • P/B of 3.26 is high for a company with failing fundamentals
  • Lack of Graham Number/Intrinsic Value data
Future
20/100

Revenue growth is not translating to bottom-line profitability.

Positives
  • Slight Q/Q revenue growth
Watchpoints
  • EPS growth is crashing
  • Consistent failure to meet analyst estimates
Past
10/100

Long-term price performance is severely negative.

Positives
No standout positives identified.
Watchpoints
  • 1Y change of -42.5%
  • Consistent downward price trajectory
Health
0/100

The 0/9 F-Score is a definitive signal of financial weakness.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 0/9
  • Missing Altman Z-Score
Dividend
0/100

Non-dividend paying stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • No payout history

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$10.93
Analyst Target
$19.23
Upside/Downside
+75.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for NIQ and closest competitors.

Updated 2026-04-30
NIQ
NIQ Global Intelligence plc
Primary
5Y
-42.5%
3Y
-42.5%
1Y
-42.5%
6M
-12.5%
1M
-3.9%
1W
-2.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
9.13
PEG Ratio
N/A
P/B Ratio
3.26
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$3.23B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth +9.23%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.1B
Gross Margin
54.8%
Op. Margin
10.3%
Net Margin
-2.8%
Total Assets
$6.8B
Liabilities
$5.6B
Equity
$1.0B
Debt/Equity
5.64x
Operating CF
$0.2B
CapEx
$-0.1B
Free Cash Flow
$0.1B
FCF Yield
48%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-14
$N/A
2026-02-27
$-0.11
-347.0% surprise
2025-11-13
$0.03
-55.8% surprise

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Advent International LP
149,380,246 shares • 2025-12-31
Kohlberg Kravis Roberts & Co. L.P.
30,022,789 shares • 2025-12-31
Surgocap Partners LP
5,858,000 shares • 2025-12-31
Vanguard Group Inc
3,995,502 shares • 2025-12-31
UBS Group AG
3,725,386 shares • 2025-12-31
DnB Asset Management AS
3,703,718 shares • 2025-12-31
Alliancebernstein L.P.
3,364,657 shares • 2025-12-31
Ameriprise Financial, Inc.
3,337,283 shares • 2025-12-31

Key Insiders

BLENKE JOHN W
Officer
BURWELL MICHAEL J.
Chief Financial Officer
HAMOOD SAMUEL A
Director
KAPOOR MOHIT
Chief Technology Officer
LOMHOLT-THOMSEN STEEN
Officer
MASSEY TRACEY ANN
Chief Operating Officer

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BLENKE JOHN W
Officer
Stock Award
2026-02-18
39,508 shares
PECK JAMES M
Chief Executive Officer
Stock Award
2026-02-18
276,558 shares
BURWELL MICHAEL J.
Chief Financial Officer
Stock Award
2026-02-18
65,847 shares
PALM JAMIE E
Officer
Stock Award
2026-02-18
12,335 shares
KAPOOR MOHIT
Chief Technology Officer
Stock Award
2026-02-18
52,678 shares
ZITTING SHAUN ELLEN
Officer
Stock Award
2026-02-18
39,508 shares
MILLER CURTIS JOHN
Officer
Stock Award
2026-02-18
39,508 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
13 analysts
Needham
2026-04-01
reit
Buy Buy
Citigroup
2026-03-06
Maintains
Neutral Neutral
Wells Fargo
2026-03-02
Maintains
Overweight Overweight
Needham
2026-03-02
Maintains
Buy Buy
Wells Fargo
2026-01-14
Maintains
Overweight Overweight
Needham
2026-01-09
reit
Buy Buy
Citigroup
2025-11-18
Maintains
Neutral Neutral
Wells Fargo
2025-11-14
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning NIQ from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile